Consumer DNA testing company 23andMe has signed a deal to acquire privately-held Lemonaid Health in a $400 million deal that marks a move into the online health sector.
An alarming number of people in England are being prescribed medicines unnecessarily, which could harm their health, according to a UK government review.
In the third part of our video round table debate on how oncology is shaping the future of personalised healthcare, the expert panel focusses on the critical role that pharmaceutical companies
In the final section of our video round table on personalised healthcare in oncology, the expert panel reviews where this space is heading, how lessons learned can apply beyond cancer and how o
Sanofi is still plugging away with its oral BTK inhibitor tolebrutinib in multiple sclerosis, but has decided to abandon efforts to develop the drug for neuromuscular diso
In the newest episode of the pharmaphorum podcast, editor-in-chief Jonah Comstock speaks with Jameka Hill, senior director of clinical trial health equity at Moderna.